The Complex Interaction Between Methamphetamine Abuse and HIV-1 Pathogenesis.

Area of Science:

• Immunology
• Virology
• Public Health

Background:

• Substance use, particularly methamphetamine (METH), is a significant barrier to controlling the global HIV/AIDS pandemic.
• METH use is associated with increased HIV transmission, delayed treatment, poor adherence, and accelerated disease progression.
• The direct impact of METH on HIV-1 disease progression is unclear due to confounding factors like non-adherence to antiretroviral therapy (ART).

Purpose of the Study:

• To systematically review the literature on the complex interaction between METH abuse and HIV-1 disease progression.
• To clarify the direct effects of METH on HIV-1 replication and pathogenesis.
• To reconcile conflicting findings from in vitro and in vivo studies regarding METH's influence on HIV-1.

Main Methods:

• Systematic literature review of published studies.
• Analysis of in vitro cell culture and animal model data.
• Examination of clinical data on METH use, ART adherence, and HIV disease markers.

Main Results:

• In vitro studies suggest METH can increase HIV-1 replication, potentially worsening pathogenesis.
• Recent data indicate METH has no effect at physiological concentrations and inhibits replication at higher concentrations in CD4+ T cells.
• Conflicting results highlight the complexity of METH's direct effects, independent of adherence issues.

Conclusions:

• The relationship between METH use and HIV-1 progression is complex and warrants further investigation.
• Understanding METH's direct effects on HIV-1 replication is crucial for developing targeted interventions.
• Future research should focus on elucidating the precise mechanisms underlying METH's impact on HIV pathogenesis.